CXCL9 and hematocrit: Notably, two proteins—CXCL9 and CCL20—previously linked to increased risk for HT in our CRO-HT biobank (manuscript under review, shown in Supplementary Materials Table S3) are also significantly associated with RE status in our current analysis.